| Authors: |
Keane EP; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts., Adri FN; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts., Larizza IS; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts., Monahan JA; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts., Song MT; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts., Boardman AC; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts., Schaefer DA; Harvard Medical School, Boston, Massachusetts; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wu JH; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Conway S; Harvard Medical School, Boston, Massachusetts; Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Brown L; Melbourne School of Psychological Sciences, University of Melbourne, Parkville, VIC, Australia., Baliousis M; Department of Clinical Psychology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center and Division of Hematology- Oncology, University of Washington, Seattle, Washington., Gudenkauf LM; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Amonoo HL; Department of Psychiatry, Mass General Brigham, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: hermioni_amonoo@dfci.harvard.edu. |
